Praxis Precision Medicines Inc
NASDAQ:PRAX

Watchlist Manager
Praxis Precision Medicines Inc Logo
Praxis Precision Medicines Inc
NASDAQ:PRAX
Watchlist
Price: 268.95 USD -2.11% Market Closed
Market Cap: 6.7B USD

Wall Street
Price Targets

PRAX Price Targets Summary
Praxis Precision Medicines Inc

Wall Street analysts forecast PRAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRAX is 410.52 USD with a low forecast of 80.8 USD and a high forecast of 798 USD.

Lowest
Price Target
80.8 USD
70% Downside
Average
Price Target
410.52 USD
53% Upside
Highest
Price Target
798 USD
197% Upside
Praxis Precision Medicines Inc Competitors:
Price Targets
TVTX
Travere Therapeutics Inc
7% Upside
MGX
Metagenomi Inc
460% Upside
ADAG
Adagene Inc
429% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
SVRA
Savara Inc
63% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
31% Upside
HALO
Halozyme Therapeutics Inc
13% Upside
BNTX
BioNTech SE
47% Upside

Revenue
Forecast

Revenue Estimate
Praxis Precision Medicines Inc

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 4 years is 202%.

N/A
Past Growth
202%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRAX's stock price target?
Price Target
410.52 USD

According to Wall Street analysts, the average 1-year price target for PRAX is 410.52 USD with a low forecast of 80.8 USD and a high forecast of 798 USD.

What is Praxis Precision Medicines Inc's Revenue forecast?
Projected CAGR
202%

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 4 years is 202%.

Back to Top